Predicting neurodevelopmental outcomes in Australian First Nations infants: The transdiagnostic utility of early screening tools
Developmental Medicine & Child Neurology · 2026-03 · 68 (3) · 381-393
DOI: 10.1111/dmcn.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 25.09.2025. Verfasst von Carly Luke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Cerebral Palsy and Rehabilitation Research Centre, Child Health Research Centre, Faculty of Health, Medicine and Behavioural Sciences, The…. Hauptthemen laut MEDLINE: Neurologic Examination, Developmental Disabilities, Neurodevelopmental Disorders, Child Development. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Research Council, Cerebral Palsy Alliance Research Foundation, Tropical Australian Academic Health Centre.
Abstract (Originalsprache)
Aim
To determine the predictive relationship between evidence‐based screening tools and neurodevelopmental outcomes in Australian First Nations infants.
Method
This prospective cohort study invited First Nations families to participate in a culturally adapted early developmental screening programme. A total of 156 infants (55.1% male, mean gestational age = 33.6 weeks, SD = 4.6) were screened using the Prechtl's General Movements Assessment, with optimality scoring using the Motor Optimality Score‐Revised (MOS‐R) at 3 to 5 months and the Hammersmith Infant Neurological Examination (HINE) at 4 to 9 months. Participants completed ‘baby movement (BM) checks’ at two time points (BM1, 3–5 months corrected age; BM2, 4–9 months corrected age), with final movement and learning checks at 12 months corrected age. At 12 months corrected age, standardized motor, cognitive, and communication assessments, neurodisability‐specific symptomology, or a diagnosis made by a paediatrician classified infants as developing typically (‘on track’) or (1) with a high chance of or confirmed cerebral palsy (CP) or (2) non‐CP neurodevelopmental delay (NDD), including autism and fetal alcohol spectrum disorder (FASD). Predictive relationships were investigated using logistic regression and diagnostic statistics.
Results
At 12 months, 127 of 147 (86%) eligible infants ( n = 9 withdrawn or deceased) were classified as ‘on track’ ( n = 55, 43%), NDD ( n = 59, 47%), or CP ( n = 13, 10%). MOS‐R (≥ 14 weeks) and the HINE distinguished infants as ‘on track’, CP, or NDD. [Correction added on 1 November 2025 after first online publication: In the preceding sentence, “MOS‐R (≥ 14 weeks). The HINE distinguished infants…” has been updated to “MOS‐R (≥ 14 weeks) and the HINE distinguished infants…”.] Each 1‐point decrease on both tools increased the odds of NDD (OR MOS‐R = 1.40, 95% confidence interval [CI] = 1.00–1.96; OR HINE = 1.12, 95% CI = 1.05–1.21) and CP (OR MOS‐R = 1.47, 95% CI = 1.08–2.01; OR HINE = 1.41, 95% CI = 1.21–1.65,). The MOS‐R (cut‐off of less than 23) and HINE (moderate to severely reduced) were best for identifying any NDD and CP (MOS‐R: sensitivity = 84%, specificity = 38%; HINE: sensitivity = 64%, specificity = 63%). Combined trajectories across both tools were the strongest predictors of CP (sensitivity = 73%, specificity = 96%), autism (sensitivity = 59%, specificity = 95%), and FASD (sensitivity = 89%, specificity = 93%).
Interpretation
Evidence‐based screening tools demonstrate promising transdiagnostic prediction of ‘on‐track’ development and not only high chance of CP but also autism, FASD, and other NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Queensland Cerebral Palsy and Rehabilitation Research Centre, Child Health Research Centre, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
- Queensland Paediatric Rehabilitation Service, Children's Health Queensland Hospital and Health Service, Brisbane, QLD, Australia.
- Griffith Biostatistics Unit, Griffith University, Brisbane, QLD, Australia.
- Department of Health and Wellbeing, Townsville Hospital and Health Service District (THHS), Townsville, QLD, Australia.
- Child Health Research Centre, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
- Beatrix Children's Hospital, Division of Neonatology, University of Groningen, Groningen, the Netherlands.
ORCID-Profile: Carly Luke, Katherine A Benfer, Arend F Bos, Roslyn N Boyd
Förderung
- HORIZON EUROPE European Research Council
- Cerebral Palsy Alliance Research Foundation
- Tropical Australian Academic Health Centre
- National Health and Medical Research Council
- Perpetual
Zitieren
APA
Luke, C., Benfer, K. A., Mick-Ramsamy, L., Ware, R. S., Bosanquet, M., Reid, N., Bos, A. F., Boyd, R. N., & Queensland State‐wide LEAP Clinical Group (2026). Predicting neurodevelopmental outcomes in Australian First Nations infants: The transdiagnostic utility of early screening tools. Developmental Medicine & Child Neurology, 68(3), 381-393. https://doi.org/10.1111/dmcn.70003
Vancouver
Luke C, Benfer KA, Mick-Ramsamy L, Ware RS, Bosanquet M, Reid N, et al. Predicting neurodevelopmental outcomes in Australian First Nations infants: The transdiagnostic utility of early screening tools. Developmental Medicine & Child Neurology. 2026;68(3):381-393. doi:10.1111/dmcn.70003
BibTeX
@article{Luke2026,
author = {Luke, Carly and Benfer, Katherine A and Mick-Ramsamy, Leeann and Ware, Robert S and Bosanquet, Margot and Reid, Natasha and Bos, Arend F and Boyd, Roslyn N and Queensland State‐wide LEAP Clinical Group, Queensland State‐wide LEAP Clinical Group},
title = {Predicting neurodevelopmental outcomes in Australian First Nations infants: The transdiagnostic utility of early screening tools},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
volume = {68},
number = {3},
pages = {381--393},
doi = {10.1111/dmcn.70003}
}
EUVIMED